Table 1.

Characteristics of subjects at time of initiation of mycophenolate mofetil. Data are number (%) or mean ± SD.

CharacteristicCTD-ILD, n = 125
Age, yrs60.4 ± 11.6
Female, n (%)52 (42)
Ethnicity, n
  White104
  Black5
  Hispanic11
  Asian1
  Other4
Smoking history, n (%)
  Never77 (62)
  Former48 (38)
Connective tissue disease, n
  Systemic sclerosis44
  Polymyositis/dermatomyositis32
  Lung-dominant connective tissue disease19
  Rheumatoid arthritis18
  Sjögren disease5
  Systemic lupus erythematosus4
  Mixed connective tissue disease3
Mode of ILD diagnosis
  Clinical/HRCT, n (%)74 (59)
  Surgical lung biopsy, n (%)51 (41)
    Pathological pattern, n
    fNSIP17
    fNSIP + OP10
    UIP14
    UIP + OP1
    OP8
    DIP1
Pulmonary physiology
  FVC%66.7 ± 16.0
  DLCO%47.4 ± 16.4
  • CTD-ILD: connective tissue disease-associated interstitial lung disease; HRCT: high-resolution computed tomography scan; DIP: desquamative interstitial pneumonia; fNSIP: fibrotic nonspecific interstitial pneumonia; OP: organizing pneumonia; UIP: usual interstitial pneumonia; FVC%: percent of predicted normal forced vital capacity for sex, ethnicity, age, and height; DLCO%: percentage of predicted normal diffusing capacity for sex, ethnicity, age, and height.